Selective inhibition of liver X receptor α-mediated lipogenesis in primary hepatocytes by licochalcone A

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1749-8546

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Selective inhibition of liver X receptor α-mediated lipogenesis in primary hepatocytes by licochalcone A ; volume:10 ; number:1 ; day:21 ; month:4 ; year:2015 ; pages:1-8 ; date:12.2015
Chinese medicine ; 10, Heft 1 (21.4.2015), 1-8, 12.2015

Creator: Oh, Gyun-Sik
Lee, Gang Gu
Yoon, Jin
Oh, Won Keun
Kim, Seung-Whan

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13020-015-0037-x

URN: urn:nbn:de:101:1-2021081510460979137275

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:55 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Oh, Gyun-Sik
Lee, Gang Gu
Yoon, Jin
Oh, Won Keun
Kim, Seung-Whan
SpringerLink (Online service)

Other Objects (12)

Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice

mir-98-5p regulates gluconeogenesis and lipogenesis by targeting PPP1R15B in hepatocytes

Retinol from hepatic stellate cells via STRA6 induces lipogenesis on hepatocytes during fibrosis

Ascorbate protects liver from metabolic disorder through inhibition of lipogenesis and suppressor of cytokine signaling 3 (SOCS3)

Coffee Bioactive N ‐Methylpyridinium: Unveiling Its Antilipogenic Effects by Targeting De Novo Lipogenesis in Human Hepatocytes

Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis

miR204 potentially promotes non-alcoholic fatty liver disease by inhibition of cpt1a in mouse hepatocytes

Preventive Effects of Acute Inflammation on Liver Cell Necrosis and Inhibition of Heparan Sulphate Synthesis in Hepatocytes

Transcriptional Regulation of De Novo Lipogenesis by SIX1 in Liver Cancer Cells

Nuclear ErbB2 expression in hepatocytes in liver disease

Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease

Fagopyrum dibotrys extract improves nonalcoholic fatty liver disease via inhibition of lipogenesis and endoplasmic reticulum stress in high-fat diet-fed mice

Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice

mir-98-5p regulates gluconeogenesis and lipogenesis by targeting PPP1R15B in hepatocytes

Retinol from hepatic stellate cells via STRA6 induces lipogenesis on hepatocytes during fibrosis

Ascorbate protects liver from metabolic disorder through inhibition of lipogenesis and suppressor of cytokine signaling 3 (SOCS3)

Coffee Bioactive N ‐Methylpyridinium: Unveiling Its Antilipogenic Effects by Targeting De Novo Lipogenesis in Human Hepatocytes

Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis

miR204 potentially promotes non-alcoholic fatty liver disease by inhibition of cpt1a in mouse hepatocytes

Preventive Effects of Acute Inflammation on Liver Cell Necrosis and Inhibition of Heparan Sulphate Synthesis in Hepatocytes

Transcriptional Regulation of De Novo Lipogenesis by SIX1 in Liver Cancer Cells

Nuclear ErbB2 expression in hepatocytes in liver disease

Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease

Fagopyrum dibotrys extract improves nonalcoholic fatty liver disease via inhibition of lipogenesis and endoplasmic reticulum stress in high-fat diet-fed mice

Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice

mir-98-5p regulates gluconeogenesis and lipogenesis by targeting PPP1R15B in hepatocytes

Retinol from hepatic stellate cells via STRA6 induces lipogenesis on hepatocytes during fibrosis

Ascorbate protects liver from metabolic disorder through inhibition of lipogenesis and suppressor of cytokine signaling 3 (SOCS3)

Coffee Bioactive N ‐Methylpyridinium: Unveiling Its Antilipogenic Effects by Targeting De Novo Lipogenesis in Human Hepatocytes

Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis

miR204 potentially promotes non-alcoholic fatty liver disease by inhibition of cpt1a in mouse hepatocytes

Preventive Effects of Acute Inflammation on Liver Cell Necrosis and Inhibition of Heparan Sulphate Synthesis in Hepatocytes

Transcriptional Regulation of De Novo Lipogenesis by SIX1 in Liver Cancer Cells

Nuclear ErbB2 expression in hepatocytes in liver disease

Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease

Fagopyrum dibotrys extract improves nonalcoholic fatty liver disease via inhibition of lipogenesis and endoplasmic reticulum stress in high-fat diet-fed mice

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Selective inhibition of liver X receptor α-mediated lipogenesis in primary hepatocytes by licochalcone A

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice

mir-98-5p regulates gluconeogenesis and lipogenesis by targeting PPP1R15B in hepatocytes

Retinol from hepatic stellate cells via STRA6 induces lipogenesis on hepatocytes during fibrosis

Ascorbate protects liver from metabolic disorder through inhibition of lipogenesis and suppressor of cytokine signaling 3 (SOCS3)

Coffee Bioactive N ‐Methylpyridinium: Unveiling Its Antilipogenic Effects by Targeting De Novo Lipogenesis in Human Hepatocytes

Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis

miR204 potentially promotes non-alcoholic fatty liver disease by inhibition of cpt1a in mouse hepatocytes

Preventive Effects of Acute Inflammation on Liver Cell Necrosis and Inhibition of Heparan Sulphate Synthesis in Hepatocytes

Transcriptional Regulation of De Novo Lipogenesis by SIX1 in Liver Cancer Cells

Nuclear ErbB2 expression in hepatocytes in liver disease

Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease

Fagopyrum dibotrys extract improves nonalcoholic fatty liver disease via inhibition of lipogenesis and endoplasmic reticulum stress in high-fat diet-fed mice

Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice

mir-98-5p regulates gluconeogenesis and lipogenesis by targeting PPP1R15B in hepatocytes

Retinol from hepatic stellate cells via STRA6 induces lipogenesis on hepatocytes during fibrosis

Ascorbate protects liver from metabolic disorder through inhibition of lipogenesis and suppressor of cytokine signaling 3 (SOCS3)

Coffee Bioactive N ‐Methylpyridinium: Unveiling Its Antilipogenic Effects by Targeting De Novo Lipogenesis in Human Hepatocytes

Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis

miR204 potentially promotes non-alcoholic fatty liver disease by inhibition of cpt1a in mouse hepatocytes

Preventive Effects of Acute Inflammation on Liver Cell Necrosis and Inhibition of Heparan Sulphate Synthesis in Hepatocytes

Transcriptional Regulation of De Novo Lipogenesis by SIX1 in Liver Cancer Cells

Nuclear ErbB2 expression in hepatocytes in liver disease

Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease

Fagopyrum dibotrys extract improves nonalcoholic fatty liver disease via inhibition of lipogenesis and endoplasmic reticulum stress in high-fat diet-fed mice

Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice

mir-98-5p regulates gluconeogenesis and lipogenesis by targeting PPP1R15B in hepatocytes

Retinol from hepatic stellate cells via STRA6 induces lipogenesis on hepatocytes during fibrosis

Ascorbate protects liver from metabolic disorder through inhibition of lipogenesis and suppressor of cytokine signaling 3 (SOCS3)

Coffee Bioactive N ‐Methylpyridinium: Unveiling Its Antilipogenic Effects by Targeting De Novo Lipogenesis in Human Hepatocytes

Insulin/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis

miR204 potentially promotes non-alcoholic fatty liver disease by inhibition of cpt1a in mouse hepatocytes

Preventive Effects of Acute Inflammation on Liver Cell Necrosis and Inhibition of Heparan Sulphate Synthesis in Hepatocytes

Transcriptional Regulation of De Novo Lipogenesis by SIX1 in Liver Cancer Cells

Nuclear ErbB2 expression in hepatocytes in liver disease

Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease

Fagopyrum dibotrys extract improves nonalcoholic fatty liver disease via inhibition of lipogenesis and endoplasmic reticulum stress in high-fat diet-fed mice

Related objects

Reset password